HDFN | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

66 results for “HDFN”

Trials

View all 48 →

Approved For Marketing

Establish a Non-invasive Prenatal Genotyping and Extraction Technology to Diagnose and Treat the HDN.

First posted Nov 21, 2016

Not yet recruiting

Prenatal Blood Typing With Next Generation Sequencing (NGS) - an Implementation Study in HDFN (PREFAB)

750 participants · First posted Jul 20, 2026

A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry

175 participants · First posted Sep 26, 2025

Drugs

DFN-529

DFN-19

DFN-14

News

View all 12 →

Nipocalimab Shows Promise in Preventing Hemolytic Disease of the Fetus and Newborn

Johnson & Johnson Halts Rheumatoid Arthritis Trial for Nipocalimab, Refocuses on Rare Disease Markets

Nipocalimab Receives FDA Breakthrough Therapy Designation for Sjögren's Disease

Page 1 of 7